Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 372.05
+12.95 (3.61%)
Sep 17, 2025, 4:07 PM CET
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.60 trillion as of September 17, 2025. Its market cap has decreased by -60.97% in one year.
Market Cap
1.60T
Enterprise Value
1.68T
Revenue
311.94B
Ranking
n/a
PE Ratio
14.39
Stock Price
372.05
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.60T, an increase of 3,368.61%. That is a compound annual growth rate of 13.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 1,595.64B | -42.44% |
| Dec 30, 2024 | 2,772.28B | -10.93% |
| Dec 29, 2023 | 3,112.33B | 46.89% |
| Dec 30, 2022 | 2,118.80B | 26.50% |
| Dec 30, 2021 | 1,674.99B | 69.77% |
| Dec 30, 2020 | 986.61B | 8.50% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Coloplast | 137.35B |
| Genmab | 109.51B |
| Demant | 52.15B |
| ALK-Abelló | 45.61B |
| H. Lundbeck | 40.58B |
| Zealand Pharma | 30.18B |
| Ambu A/S | 25.93B |
| Bavarian Nordic | 18.18B |